Ariston Services Group Raises Holdings in UnitedHealth Group Incorporated $UNH

Ariston Services Group raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 19.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 839 shares of the healthcare conglomerate’s stock after purchasing an additional 134 shares during the period. UnitedHealth Group makes up about 0.4% of Ariston Services Group’s investment portfolio, making the stock its 29th largest holding. Ariston Services Group’s holdings in UnitedHealth Group were worth $439,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group in the 4th quarter worth $26,000. Bayforest Capital Ltd boosted its stake in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares during the last quarter. Kapitalo Investimentos Ltda purchased a new position in shares of UnitedHealth Group in the 4th quarter worth $41,000. Finally, Copia Wealth Management purchased a new position in shares of UnitedHealth Group in the 4th quarter worth $42,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares of the company’s stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.28% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $307.0980 on Friday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The business’s 50-day simple moving average is $288.39 and its two-hundred day simple moving average is $389.57. The stock has a market cap of $278.13 billion, a PE ratio of 13.31, a P/E/G ratio of 1.96 and a beta of 0.43. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on UNH shares. TD Securities restated a “hold” rating and issued a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Erste Group Bank cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. JPMorgan Chase & Co. decreased their target price on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a report on Wednesday, August 6th. Barclays reaffirmed an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, Wells Fargo & Company decreased their target price on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Fifteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $365.38.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.